 The effects of haploidentical rhG-CSF-mobilized unmanipulated blood and marrow transplantation HBMT on hematological malignancies are well established.The aim of this prospective cohort trial is to determine if acute graft-versus-host disease aGVHD could be decreased with IL2 therapy post HBMT. 